Anti-Nogo-A Antibody Treatment and Cell Body Shrinkage in Monkeys
Author Information
Author(s): Beaud Marie-Laure, Schmidlin Eric, Wannier Thierry, Freund Patrick, Bloch Jocelyne, Mir Anis, Schwab Martin E, Rouiller Eric M
Primary Institution: University of Fribourg
Hypothesis
Does anti-Nogo-A treatment prevent soma shrinkage in corticospinal neurons after cervical cord lesion?
Conclusion
The anti-Nogo-A antibody treatment did not prevent soma shrinkage in axotomized corticospinal neurons.
Supporting Evidence
- Anti-Nogo-A treatment did not prevent shrinkage of corticospinal neurons.
- Most axotomized corticospinal neurons survived the injury.
- Functional recovery was enhanced by anti-Nogo-A treatment.
Takeaway
Researchers wanted to see if a special treatment could stop brain cells from getting smaller after an injury, but it didn't work.
Methodology
Monkeys were divided into three groups: intact, control antibody treated, and anti-Nogo-A antibody treated, and their motor cortex neurons were analyzed.
Potential Biases
Potential variability in individual responses to treatment and the small sample size may introduce bias.
Limitations
The study did not assess the effects of higher doses of anti-Nogo-A antibody or its delivery at cortical levels.
Participant Demographics
Adult macaque monkeys, with varying degrees of cervical cord lesions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website